Nepentes Pharma Sp z oo-Strategy, SWOT and Corporate Finance Report

Nepentes Pharma Sp z oo-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Nepentes Pharma Sp z oo required for business and competitor intelligence needs

A study of the major internal and external factors affecting Nepentes Pharma Sp z oo in the form of a SWOT analysis

An in-depth view of the business model of Nepentes Pharma Sp z oo including a breakdown and examination of key business segments

Intelligence on Nepentes Pharma Sp z oo's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Nepentes Pharma Sp z oo, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

Gain understanding of Nepentes Pharma Sp z oo and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Nepentes Pharma Sp z oo as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Nepentes Pharma Sp z oo's business structure, strategy and prospects.

Key Highlights

Nepentes Pharma Sp z oo (Nepentes) is a pharmaceutical company based in Poland. The company develops, manufactures and sells formulations and solutions of dermatology, paediatrics and cough and cold. Its products are marketed under Iwostin, Emolium, Elixine, Propodia and Propolki brands. The company sells its products across Poland and other countries of the central and Eastern Europe region. In addition, the company sells various internationally-recognized pharmaceutical brands, comprising neo-angin, Sudocrem, Melisana Klosterfrau and Marimer. It owns and manages a production facility in Chociw, Poland. The company also operates through its affiliates in Bulgaria and Romania. Nepentes is headquartered in Warsaw, Poland.